Isatin Derivatives and Their Antiviral Properties Against Arboviruses: A Review
-
Published:2018-12-06
Issue:1
Volume:19
Page:56-62
-
ISSN:1389-5575
-
Container-title:Mini-Reviews in Medicinal Chemistry
-
language:en
-
Short-container-title:MRMC
Author:
De Moraes Gomes Paulo André Teixeira1, Pena Lindomar J.2, Leite Ana C. Lima1
Affiliation:
1. Medicinal Chemistry Planning Laboratory, Department of Pharmaceutical Sciences, Federal University of Pernambuco, Recife-PE, Brazil 2. Department of Virology and of Experimental Therapeutics, Aggeu Magalhães Institute, Oswaldo Cruz Foundation (Fiocruz), Recife-PE, Brazil
Abstract
Arboviruses have been spreading rapidly throughout the Western Hemisphere in recent decades.
Among the arboviruses with high morbidity and mortality are the members of the Alphavirus and
Flavivirus genera. Within the first genus, Chikungunya Virus (CHIKV) is considered one of the most
challenging human arboviral infection worldwide, against which there is no specific antivirals. Flaviviruses
are some of the main viruses responsible for encephalitis, haemorrhagic disease and developmental
defects. Dengue virus (DENV), Japanese Encephalitis Virus (JEV), West Nile Virus (WNV) and
Zika Virus (ZIKV) are examples of flaviviruses without clinically approved antiviral agents. Thus, the
search for new antivirals becomes highly important. One of the strategies that can be employed to obtain
new drugs is the identification and utilization of privileged structures. Isatin is an example of a
privileged molecular framework, displaying a broad spectrum of biological activities, including antiviral
action. Obtaining and studying the antiviral properties of isatin derivatives have helped to identify
important agents with potential activity against different arboviruses. This article reviews some of
these isatin derivatives, their structures and antiviral properties reported against this important group of
viruses.
Publisher
Bentham Science Publishers Ltd.
Subject
Drug Discovery,Pharmacology,General Medicine
Reference39 articles.
1. Fauci AS, Morens DM. N Engl J Med, Zika Virus in the Americas—Yet Another Arbovirus Threat.,, 2016, ,, -,10.1056/NEJMp1600297 2. Wahid B, Ali A, Rafique S, Idrees M. Int J Infect Dis, Global expansion of chikungunya virus: mapping the 64-year history.,, 2017, 58,, 69-76, 3. Rashad AA, Keller PA. J Mol Graph Model, Structure based design towards the identification of novel binding sites and inhibitors for the Chikungunya virus envelope proteins.,, 2013, 44,, 241-252, 4. Jadav SS, Korupolu P, Sinha BN, Jayaprakash V. J Pharmaceut Chem, Chikungunya epidemiological survey and Current available inhibitors.,, 2014, 1,, 59-67, 5. Puig-Basagoiti F, Tilgner M, Forshey BM, Philpott SM, Espina NG, Wentworth DE, Goebel SJ, Masters PS, Falgout B, Ren P, Ferguson DM. Antimicrob Agents Chemother, Triaryl pyrazoline compound inhibits flavivirus RNA replication.,, 2006, 50,, 1320-1329,
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|